CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...
Due to the “programmable” nature of the nanoparticle, researchers are able to “swap out the antibodies or the drugs to target ...
Researchers developed a topical gene therapy that corrects disease-causing mutations in human skin models using lipid ...
Researchers are studying liposomes to understand and block the spread of metastases, paving the way for new cancer treatments ...
Researchers have demonstrated that liposomes target tumours more effectively and reduce side effects, while others have observed that these nanomedicines improve the penetration and specificity of ...
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
Understanding these microscopic messengers could change the fight against metastasis. Preventing cancer from spreading ...
New research reveals the mechanism by which obesity leads to uncontrolled inflammation, potentially resulting in serious ...
News Medical on MSN
First topical CRISPR gene therapy corrects disease-causing mutations in human skin
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...
A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results